5 serious virus patients cured in experimental trial in Jerusalem

Enlivex Therapeutics says five coronavirus patients have recovered from the virus within days after being administered the Allocetra immunotherapy in a clinical trial at Jerusalem’s Hadassah hospital.

“The clinical trial included five COVID-19 patients, three in severe condition and two in critical condition. All five patients had complete recovery from their respective severe/critical condition and were released from the hospital after an average of 5.5 days (severe) and 8.5 days (critical), following administration of AllocetraTM, at which time they were all COVID-19 PCR negative,” a statement says.

“There were no reported severe adverse events relating to the administration of AllocetraTM in the patients, and the therapy was well-tolerated,” it says.

Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed